T1 mapping in myocarditis-headway to a new era for cardiovascular magnetic resonance

Expert Review of Cardiovascular Therapy

Volumn 13, Issue 8, 2015, Pages 871-874

  Hinojar, Rocio ^a   Nagel, Eike ^b   Puntmann, Valentina O ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Lake Louise criteria; myocardial inflammation; myocarditis; T1 mapping

Indexed keywords

CARDIOVASCULAR MAGNETIC RESONANCE; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EDITORIAL; HEART MUSCLE BIOPSY; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MYOCARDITIS; PREDICTIVE VALUE; TISSUE CHARACTERIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES;

HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDITIS;

EID: 84937569091     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2015.1051035     Document Type: Editorial

References (28)

1. Caforio AL, Pankuweit S, Arbustini E, et al. European society of cardiology working group on myocardial and pericardial diseases. current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2013;34: 2636-48
2. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol 2012;59:779-92
3. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American heart association, the american college of cardiology, and the european society of cardiology endorsed by the heart failure society of America and the heart failure association of the european society of cardiology. Eur Heart J 2007;28:3076-93
4. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8
5. Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging 2012;5(5):513-24
6. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53(17):1475-87
7. Chu GW, Flewitt J, Mikami Y, et al. Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols. Int J Cardiovasc Imaging 2013;29:1077-83
8. Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012;59:1604-15
9. Francone M, Chimenti C, Galea N, et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovasc Imaging 2014;7:254-63
10. Rehwald WG, Fieno DS, Chen EL, et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105(2):224-9
11. Coelho-Filho OR, Mongeon FP, Mitchell R, et al. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging 2013;6(1):134-41
12. Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013;6(4): 475-84
13. Puntmann VO, Taylor PC, Barr A, et al. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study. Rheumatology (Oxford) 2010;49:528-35
14. Puntmann VO, D'Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 2013;6(2):295-01
15. Hinojar R, Foote L, Arroyo Ucar E, et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging 2015;8(1):37-46
16. Ferreira VM, Piechnik SK, Dall'Armellina E, et al. T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 2013; 6(10):1048-58
17. Dall'Armellina E, Ferreira VM, Kharbanda RK, et al. Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction. JACC Cardiovasc Imaging 2013;6(6):739-42
18. Dabir D, Child N, Kalra A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014;16:69
19. Friedrich MG. Myocardial T1: the rise of a novel biomarker continues. JACC Cardiovasc Imaging 2015;8(1):47-9
20. Kramer CM, Chandrashekhar Y, Narula J. Is it T1me for tissue characterization in myocarditis? JACC Cardiovasc Imaging 2015;8(1):115-17
21. Radunski UK, Lund GK, Stehning C, et al. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging 2014; 7(7):667-75
22. Luetkens JA, Doerner J, Thomas DK, et al. Acute myocarditis: multiparametric cardiac MR imaging. Radiology 2014;273(2): 383-92
23. Hinojar R, Foote L, Arroyo Ucar E, et al. Myocardial T2 mapping for improved detection of inflammatory myocardial involvement in acute and chronic myocarditis. J Cardiovas Magnet Res 2014; 16(Suppl 1):O63
24. Puntmann VO, Foote L, Hinojar R, et al. 130 reproducibility of T1 and T2 mapping in health and disease, and assessment of T2 variability across the normal myocardium. Heart 2014;100(Suppl 3):A76
25. Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging 2012;5(1):102-10
26. Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging 2012; 5(6):596-603
27. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009;30:1995-02
28. Felix SB, Staudt A, Dorffel WV, et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three month results from a randomized trial. J Am Coll Cardiol 2000;35:1590-8